Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Multimodal 18F-AV-1451 and MRI findings in non-fluent variant primary progressive aphasia: possible insights on nodal propagation of tau protein across the syntactic network.

Pascual B, Funk Q, Zanotti-Fregonara P, Pal N, Rockers E, Yu MM, Spann B, Román GC, Schulz PE, Karmonic C, Appel SH, Masdeu JC.

J Nucl Med. 2019 Jul 26. pii: jnumed.118.225508. doi: 10.2967/jnumed.118.225508. [Epub ahead of print]

PMID:
31350322
2.

Head-to-head comparison of 11C-PBR28 and 11C-ER176 for quantification of the translocator protein in the human brain.

Zanotti-Fregonara P, Pascual B, Veronese M, Yu M, Beers D, Appel SH, Masdeu JC.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1822-1829. doi: 10.1007/s00259-019-04349-w. Epub 2019 May 31.

PMID:
31152207
3.

Anatomical evaluation of the extent of spread in the erector spinae plane block: a cadaveric study.

Aponte A, Sala-Blanch X, Prats-Galino A, Masdeu J, Moreno LA, Sermeus LA.

Can J Anaesth. 2019 Aug;66(8):886-893. doi: 10.1007/s12630-019-01399-4. Epub 2019 May 21.

PMID:
31119551
4.

Education Research: Neuroradiology curriculum in neurology residency training programs: How we teach neuroimaging.

Johnson PD, Sillau S, Masdeu JC, Ney DE, Korb PJ.

Neurology. 2019 Jan 22;92(4):199-203. doi: 10.1212/WNL.0000000000006812.

PMID:
30665912
5.

The validity of 18F-GE180 as a TSPO imaging agent.

Zanotti-Fregonara P, Veronese M, Pascual B, Rostomily RC, Turkheimer F, Masdeu JC.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1205-1207. doi: 10.1007/s00259-019-4268-4. Epub 2019 Jan 17. No abstract available.

PMID:
30656358
6.

"Ears of the Lynx" MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia.

Pascual B, de Bot ST, Daniels MR, França MC Jr, Toro C, Riverol M, Hedera P, Bassi MT, Bresolin N, van de Warrenburg BP, Kremer B, Nicolai J, Charles P, Xu J, Singh S, Patronas NJ, Fung SH, Gregory MD, Masdeu JC.

AJNR Am J Neuroradiol. 2019 Jan;40(1):199-203. doi: 10.3174/ajnr.A5935. Epub 2019 Jan 3.

PMID:
30606727
7.

Functional alterations of myeloid cells during the course of Alzheimer's disease.

Thome AD, Faridar A, Beers DR, Thonhoff JR, Zhao W, Wen S, Pascual B, Masdeu JC, Appel SH.

Mol Neurodegener. 2018 Nov 13;13(1):61. doi: 10.1186/s13024-018-0293-1.

8.

Clinical Findings in a Multicenter MRI Study of Mild TBI.

Shetty T, Nguyen JT, Cogsil T, Tsiouris AJ, Niogi SN, Kim EU, Dalal A, Halvorsen K, Cummings K, Zhang T, Masdeu JC, Mukherjee P, Marinelli L.

Front Neurol. 2018 Oct 23;9:836. doi: 10.3389/fneur.2018.00836. eCollection 2018.

9.

Reader response: The neurologic exam: Is it extinct?

Masdeu JC.

Neurology. 2018 Aug 14;91(7):333. doi: 10.1212/WNL.0000000000005990. No abstract available.

PMID:
30104232
10.

Longitudinal Resting State Functional Connectivity Predicts Clinical Outcome in Mild Traumatic Brain Injury.

Madhavan R, Joel SE, Mullick R, Cogsil T, Niogi SN, Tsiouris AJ, Mukherjee P, Masdeu JC, Marinelli L, Shetty T.

J Neurotrauma. 2019 Mar 1;36(5):650-660. doi: 10.1089/neu.2018.5739. Epub 2018 Oct 3.

PMID:
30024343
11.

Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain.

Zanotti-Fregonara P, Pascual B, Rizzo G, Yu M, Pal N, Beers D, Carter R, Appel SH, Atassi N, Masdeu JC.

J Nucl Med. 2018 Aug;59(8):1260-1266. doi: 10.2967/jnumed.117.203109. Epub 2018 Jan 18.

12.

A Biomarker Combining Imaging and Neuropsychological Assessment for Tracking Early Alzheimer's Disease in Clinical Trials.

Verma N, Beretvas SN, Pascual B, Masdeu JC, Markey MK; Alzheimer's Disease Neuroimaging Initiative.

Curr Alzheimer Res. 2018 Mar 14;15(5):429-442. doi: 10.2174/1567205014666171106150309.

PMID:
29110613
13.

Letter re: High hypothetical interest in physician-assisted death in multiple sclerosis.

Masdeu JC.

Neurology. 2017 Sep 26;89(13):1428. doi: 10.1212/WNL.0000000000004431. No abstract available.

PMID:
28947581
14.

BDNF Val66Met polymorphism tunes frontolimbic circuitry during affective contextual learning.

Jabbi M, Cropp B, Nash T, Kohn P, Kippenhan JS, Masdeu JC, Mattay R, Kolachana B, Berman KF.

Neuroimage. 2017 Nov 15;162:373-383. doi: 10.1016/j.neuroimage.2017.08.080. Epub 2017 Sep 1.

15.

Tau and Cortical Thickness in Alzheimer Disease.

Masdeu JC.

JAMA Neurol. 2017 Apr 1;74(4):390-392. doi: 10.1001/jamaneurol.2016.5701. No abstract available.

PMID:
28241165
16.

Detecting synaptic autoantibodies in psychoses: need for more sensitive methods.

Masdeu JC.

Curr Opin Neurol. 2017 Jun;30(3):317-326. doi: 10.1097/WCO.0000000000000447. Review.

PMID:
28234799
17.

Future Directions in Imaging Neurodegeneration.

Masdeu JC.

Curr Neurol Neurosci Rep. 2017 Jan;17(1):9. doi: 10.1007/s11910-017-0718-1. Review.

PMID:
28210978
18.

Preface.

Masdeu JC, González RG.

Handb Clin Neurol. 2016;135:ix. doi: 10.1016/B978-0-444-53485-9.09988-8. No abstract available.

PMID:
27432688
19.

Inherited or acquired metabolic disorders.

Eichler F, Ratai E, Carroll JJ, Masdeu JC.

Handb Clin Neurol. 2016;135:603-636. doi: 10.1016/B978-0-444-53485-9.00029-5. Review.

PMID:
27432685
20.

Genetic and degenerative disorders primarily causing dementia.

Masdeu JC, Pascual B.

Handb Clin Neurol. 2016;135:525-564. doi: 10.1016/B978-0-444-53485-9.00026-X. Review.

PMID:
27432682
21.

Preface.

Masdeu JC, González RG.

Handb Clin Neurol. 2016;136:ix. doi: 10.1016/B978-0-444-53486-6.09986-5. No abstract available.

PMID:
27430473
22.

Brain CT and MRI: differential diagnosis of imaging findings.

Masdeu JC, Gadhia R, Faridar A.

Handb Clin Neurol. 2016;136:1037-54. doi: 10.1016/B978-0-444-53486-6.00054-5. Review.

PMID:
27430457
23.

Gait and balance disorders.

Masdeu JC.

Handb Clin Neurol. 2016;136:939-55. doi: 10.1016/B978-0-444-53486-6.00048-X. Review.

PMID:
27430451
24.

NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?

Masdeu JC, Dalmau J, Berman KF.

Trends Neurosci. 2016 May;39(5):300-310. doi: 10.1016/j.tins.2016.02.006. Epub 2016 Apr 26. Review.

25.

Common Variation in the DOPA Decarboxylase (DDC) Gene and Human Striatal DDC Activity In Vivo.

Eisenberg DP, Kohn PD, Hegarty CE, Ianni AM, Kolachana B, Gregory MD, Masdeu JC, Berman KF.

Neuropsychopharmacology. 2016 Aug;41(9):2303-8. doi: 10.1038/npp.2016.31. Epub 2016 Feb 29.

26.

Tau, amyloid, and hypometabolism in the logopenic variant of primary progressive aphasia.

Pascual B, Masdeu JC.

Neurology. 2016 Feb 2;86(5):487-8. doi: 10.1212/WNL.0000000000002340. No abstract available.

PMID:
26833938
27.

New scoring methodology improves the sensitivity of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials.

Verma N, Beretvas SN, Pascual B, Masdeu JC, Markey MK; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2015 Nov 12;7(1):64. doi: 10.1186/s13195-015-0151-0.

28.

In Memoriam: Frank A. Rubino, MD.

Freeman WD, Brazis PW, Biller J, Masdeu JC, Merrilees GR, Olson S.

JAMA Neurol. 2015 Nov;72(11):1384-5. doi: 10.1001/jamaneurol.2015.2308. No abstract available.

PMID:
26551966
29.

Advanced Neuroimaging Methods Towards Characterization of Early Stages of Alzheimer's Disease.

Sepulcre J, Masdeu JC.

Methods Mol Biol. 2016;1303:509-19. doi: 10.1007/978-1-4939-2627-5_31. Review.

PMID:
26235088
30.

Large-scale brain networks of the human left temporal pole: a functional connectivity MRI study.

Pascual B, Masdeu JC, Hollenbeck M, Makris N, Insausti R, Ding SL, Dickerson BC.

Cereb Cortex. 2015 Mar;25(3):680-702. doi: 10.1093/cercor/bht260. Epub 2013 Sep 24.

31.

Intracranial arteries in individuals with the elastin gene hemideletion of Williams syndrome.

Wint DP, Butman JA, Masdeu JC, Meyer-Lindenberg A, Mervis CB, Sarpal D, Morris CA, Berman KF.

AJNR Am J Neuroradiol. 2014 Jan;35(1):90-4. doi: 10.3174/ajnr.A3641. Epub 2013 Jul 18.

32.

Searching for novelty: challenges with open access data.

Masdeu JC.

Ann Neurol. 2012 Dec;72(6):983. doi: 10.1002/ana.23755. No abstract available.

PMID:
23280847
33.

Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.

Masdeu JC, González-Pinto A, Matute C, Ruiz De Azúa S, Palomino A, De Leon J, Berman KF, Dalmau J.

Am J Psychiatry. 2012 Oct;169(10):1120-1. doi: 10.1176/appi.ajp.2012.12050646. No abstract available.

34.

Decreased carbon-11-flumazenil binding in early Alzheimer's disease.

Pascual B, Prieto E, Arbizu J, Marti-Climent JM, Peñuelas I, Quincoces G, Zarauza R, Pappatà S, Masdeu JC.

Brain. 2012 Sep;135(Pt 9):2817-25. doi: 10.1093/brain/aws210.

PMID:
22961552
35.

Interactive effect of apolipoprotein e genotype and age on hippocampal activation during memory processing in healthy adults.

Nichols LM, Masdeu JC, Mattay VS, Kohn P, Emery M, Sambataro F, Kolachana B, Elvevåg B, Kippenhan S, Weinberger DR, Berman KF.

Arch Gen Psychiatry. 2012 Aug;69(8):804-13. doi: 10.1001/archgenpsychiatry.2011.1893.

PMID:
22868934
36.

The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow.

Goker-Alpan O, Masdeu JC, Kohn PD, Ianni A, Lopez G, Groden C, Chapman MC, Cropp B, Eisenberg DP, Maniwang ED, Davis J, Wiggs E, Sidransky E, Berman KF.

Brain. 2012 Aug;135(Pt 8):2440-8. doi: 10.1093/brain/aws174.

37.

The neurobiology of Alzheimer disease defined by neuroimaging.

Masdeu JC, Kreisl WC, Berman KF.

Curr Opin Neurol. 2012 Aug;25(4):410-20. doi: 10.1097/WCO.0b013e3283557b36. Review.

PMID:
22766722
38.

Imaging brain networks and brain diseases.

Masdeu JC.

Curr Opin Neurol. 2012 Aug;25(4):373-4. doi: 10.1097/WCO.0b013e328355a300. No abstract available.

PMID:
22710360
39.

Midbrain presynaptic dopamine tone predicts sustained and transient neural response to emotional salience in humans: fMRI, MEG and FDOPA PET.

Jabbi M, Nash T, Kohn P, Ianni A, Rubinstein D, Holroyd T, Carver FW, Masdeu JC, Kippenhan JS, Robinson SE, Coppola R, Berman KF.

Mol Psychiatry. 2013 Jan;18(1):4-6. doi: 10.1038/mp.2012.12. Epub 2012 Mar 13. No abstract available.

40.

Isolated and prolonged loss of time orientation.

Masdeu JC.

Neurology. 2011 Sep 13;77(11):1104-5; authore reply 1105. doi: 10.1212/WNL.0b013e3182294151. No abstract available.

PMID:
21911737
41.

Neuroimaging in psychiatric disorders.

Masdeu JC.

Neurotherapeutics. 2011 Jan;8(1):93-102. doi: 10.1007/s13311-010-0006-0. Review.

42.

Brain glucose metabolism in vascular white matter disease with dementia: differentiation from Alzheimer disease.

Pascual B, Prieto E, Arbizu J, Marti-Climent J, Olier J, Masdeu JC.

Stroke. 2010 Dec;41(12):2889-93. doi: 10.1161/STROKEAHA.110.591552. Epub 2010 Nov 4.

PMID:
21051671
43.

Seasonal effects on human striatal presynaptic dopamine synthesis.

Eisenberg DP, Kohn PD, Baller EB, Bronstein JA, Masdeu JC, Berman KF.

J Neurosci. 2010 Nov 3;30(44):14691-4. doi: 10.1523/JNEUROSCI.1953-10.2010.

44.

Lexical access changes in patients with multiple sclerosis: a two-year follow-up study.

Sepulcre J, Peraita H, Goni J, Arrondo G, Martincorena I, Duque B, Velez de Mendizabal N, Masdeu JC, Villoslada P.

J Clin Exp Neuropsychol. 2011 Feb;33(2):169-75. doi: 10.1080/13803395.2010.499354. Epub 2010 Sep 10.

PMID:
20835944
45.

EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.

Filippi M, Agosta F, Abrahams S, Fazekas F, Grosskreutz J, Kalra S, Kassubek J, Silani V, Turner MR, Masdeu JC; European Federation of Neurological Societies.

Eur J Neurol. 2010 Apr;17(4):526-e20. doi: 10.1111/j.1468-1331.2010.02951.x. Epub 2010 Feb 2.

46.

White matter lesions predispose to falls in older people.

Masdeu JC, Wolfson L.

Stroke. 2009 Sep;40(9):e546. doi: 10.1161/STROKEAHA.109.558122. Epub 2009 Jul 23. No abstract available.

PMID:
19628802
47.

Brain pathways of verbal working memory: a lesion-function correlation study.

Sepulcre J, Masdeu JC, Pastor MA, Goñi J, Barbosa C, Bejarano B, Villoslada P.

Neuroimage. 2009 Aug 15;47(2):773-8. doi: 10.1016/j.neuroimage.2009.04.054. Epub 2009 Apr 23.

PMID:
19393745
48.

Ventricular wall granulations and draining of cerebrospinal fluid in chronic giant hydrocephalus.

Masdeu JC, Pascual B, Bressi F, Casale M, Prieto E, Arbizu J, Fernández-Seara MA.

Arch Neurol. 2009 Feb;66(2):262-7. doi: 10.1001/archneurol.2008.547.

PMID:
19204166
49.

Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.

Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.

Arch Neurol. 2009 Feb;66(2):173-9. doi: 10.1001/archneurol.2008.562.

PMID:
19204153
50.

A patient with MV2 subtype of sporadic Creutzfeldt-Jakob disease and atypical clinical presentation.

Guerrero D, Martínez-Velilla N, Caballero MC, Mendióroz MT, Tuñón T, Masdeu J, Rodríguez A, Armstrong J, Ferrer I.

Clin Neuropathol. 2008 Nov-Dec;27(6):408-13.

PMID:
19130739

Supplemental Content

Loading ...
Support Center